Humoral and cellular response of two different vaccines against SARS-CoV-2 in a group of healthcare workers: An observational study
Description
On March 13, 2021, Tunisia started a widespread immunization program against SARS-CoV-2 utilizing different vaccinations that had been given emergency approval. Herein, we followed prospectively a cohort of participant who received COVID-19 vaccine
